You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 146 No. 9, September 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (48)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Aging and the Kidney

Wendy W. Brown, MD; Bernard B. Davis, MD; Leslie A. Spry, MD; Nirandon Wongsurawat, MD; J. David Malone, MD; Douglass T. Domoto, MD

Arch Intern Med. 1986;146(9):1790-1796.


Abstract



• Numerous anatomic and physiologic alterations occur in the kidney with aging. These changes affect the ability of elderly patient(s) to maintain homeostasis and alter response to medications, stress, illness, or changes in diet, mobility, or environment. Drug-induced illness and drug interactions are major problems in the elderly. Bone disease and fractures are associated with negative calcium balance and decreased production of 1,25-dihydrocholecalciferol seen with aging. The geriatric patient is not immune to the primary glomerular diseases that occur in younger patients, although the relative incidence of pathologic diagnoses may differ. The high incidence of membranous glomerulonephritis in the elderly, and the well-known association between malignancy and membranous nephropathy strongly favor aggressive evaluation of the nephrotic syndrome in the geriatric age group. Attention must be given to consideration of appropriate end-stage renal disease treatment alternatives for the geriatric population, which now comprises the fastest-growing segment of the endstage renal disease population.

(Arch Intern Med 1986;146:1790-1796)



Author Affiliations



From the Medical Service (Drs Brown, Spry, and Malone) and the Geriatric Research, Education, and Clinical Center (Drs Davis and Wongsurawat), St Louis Veterans Administration Medical Center; and the Department of Internal Medicine (Drs Brown, Davis, Spry, Wongsurawat, Malone, and Domoto), St Louis University School of Medicine.


Footnotes



Accepted for publication Dec 9, 1985.

Reprint requests to Medical Service (111-JC), Veterans Administration Medical Center, St Louis, MO 63125 (Dr Davis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cancer Chemotherapy in the Elderly
Sekine et al.
Jpn J Clin Oncol 1998;28:463-473.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis
Hodsman et al.
J. Clin. Endocrinol. Metab. 1997;82:620-628.
ABSTRACT | FULL TEXT  

latrogenic Renal Disease
Davidman et al.
Arch Intern Med 1991;151:1809-1812.
ABSTRACT  

Difficulties in Estimating Glomerular Filtration Rate in the Elderly
Goldberg and Finkelstein
Arch Intern Med 1987;147:1430-1433.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.